Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Foslevodopa

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 415Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Foslevodopa, Dopa 4-phosphate, 3-hydroxy-o-phosphono-l-tyrosine, 97321-87-4, Foslevodopa [usan], 101141-95-1
    Molecular Formula
    C9H12NO7P
    Molecular Weight
    277.17  g/mol
    InChI Key
    YNDMEEULGSTYJT-LURJTMIESA-N
    FDA UNII
    37NQZ0J76I
    Foslevodopa is under investigation in clinical trial NCT04750226 (Study to Assess Adverse Events and Change in Disease Activity of 24-hour Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Advanced Parkinson's Disease).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-2-amino-3-(3-hydroxy-4-phosphonooxyphenyl)propanoic acid
    2.1.2 InChI
    InChI=1S/C9H12NO7P/c10-6(9(12)13)3-5-1-2-8(7(11)4-5)17-18(14,15)16/h1-2,4,6,11H,3,10H2,(H,12,13)(H2,14,15,16)/t6-/m0/s1
    2.1.3 InChI Key
    YNDMEEULGSTYJT-LURJTMIESA-N
    2.1.4 Canonical SMILES
    C1=CC(=C(C=C1CC(C(=O)O)N)O)OP(=O)(O)O
    2.1.5 Isomeric SMILES
    C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)OP(=O)(O)O
    2.2 Other Identifiers
    2.2.1 UNII
    37NQZ0J76I
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Dopa 4-phosphate

    2. Dopa 4-phosphate, (32)p-(l-tyr)-isomer

    3. Dopa 4-phosphate, (l-tyr)-isomer

    2.3.2 Depositor-Supplied Synonyms

    1. Foslevodopa

    2. Dopa 4-phosphate

    3. 3-hydroxy-o-phosphono-l-tyrosine

    4. 97321-87-4

    5. Foslevodopa [usan]

    6. 101141-95-1

    7. 37nqz0j76i

    8. Abbv-951

    9. (2s)-2-amino-3-(3-hydroxy-4-phosphonooxyphenyl)propanoic Acid

    10. Abbv-951 Component Foslevodopa

    11. Foslevodopa [inn]

    12. Foslevodopa [jan]

    13. Unii-37nqz0j76i

    14. 3-hydroxy-o-phosphonotyrosine

    15. Foslevodopa (jan/usan/inn)

    16. Chembl4594379

    17. Schembl17685899

    18. Dtxsid70905957

    19. Chebi:192509

    20. Who 11006

    21. Hy-109132

    22. L-tyrosine, 3-hydroxy-o-phosphono-

    23. Cs-0086774

    24. D11839

    25. L-tyrosine, 3-hydroxy-, 4-(dihydrogen Phosphate)

    26. (s)-2-amino-3-(3-hydroxy-4-(phosphonooxy)phenyl)propanoic Acid

    27. (2s)-2-amino-3-[3-hydroxy-4-(phosphonooxy)phenyl]propanoic Acid

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 277.17 g/mol
    Molecular Formula C9H12NO7P
    XLogP3-4
    Hydrogen Bond Donor Count5
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count5
    Exact Mass277.03513872 g/mol
    Monoisotopic Mass277.03513872 g/mol
    Topological Polar Surface Area150 Ų
    Heavy Atom Count18
    Formal Charge0
    Complexity344
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1